Israel Finds Fourth COVID Booster is only ‘Partially Effective,’ Vast Majority of Hospitalised Omicron Patients Are Unvaccinated 17/01/2022 Maayan Hoffman & Kerry Cullinan A fourth COVID-19 booster mRNA vaccine has proven ineffective against Omicron infection, according to preliminary research from Israel released on Monday. “Despite a significant increase in antibodies after the fourth vaccine, this protection is only partially effective against the Omicron strain, which is relatively resistant to the vaccine,” lead researcher Prof Gili Regev-Yochay, told a […] Continue reading -> France Approves COVID-19 Vaccine Pass Law, Joins Other EU Countries With COVID Fines and Mandates 17/01/2022 Raisa Santos France’s newest measure to tackle COVID-19 – requiring a certificate of vaccination at public places such as restaurants, cafes, cinemas, and long-distance trains – was approved by its parliament on Sunday. With lawmakers in the lower house of parliament voting 215 to 58 in favour, the law is set to be enforced in coming days. […] Continue reading -> COVAX Delivers One Billionth COVID-19 Vaccine Dose – But 41% of World Remains Unvaccinated 17/01/2022 Kerry Cullinan Rwanda became the recipient of the one-billionth COVID-19 vaccine delivered by COVAX, the global platform set up to ensure equitable access to the vaccines,announced last Friday. After numerous supply problems – most seriously when its key supplier, the Serum Insitute of India, was banned from exporting its vaccines by the Indian government – COVAX was […] Continue reading -> Throat Swab? Nose? Best Test Yet of Omicron’s Spread May be a Sewage Sample 14/01/2022 Maayan Hoffman Two years into the COVID-19 pandemic, monitoring sewage for evidence of disease – in this case COVID-19 – may be on the verge of becoming mainstream. At least that is what some trend-setting researchers are hoping to detect rising SARS-CoV2 infections early and set policies based on data even before swab testing can provide it. […] Continue reading -> WHO Recommends Two New COVID-19 Treatments – Cost and Availability Likely Barriers 14/01/2022 Maayan Hoffman Two new treatments for COVID-19 were recommended on Thursday by the World Health Organization’s Guideline Development Group of international experts – one for severely ill patients and the other for those patients who are not severely ill but most likely to develop severe disease. The recommendations were announced Friday morning in the BMJ. Both drugs, […] Continue reading -> WHO Africa Region: COVID-19 Vaccination Shifting from Supply-Side to Distribution Challenge 13/01/2022 Paul Adepoju COVID-19 vaccination in Africa may be shifting from a supply challenge – to one of effective vaccine distribution, declared a senior World Health Organization official in the African Region on Thursday. African countries will have adequate access to COVID-19 vaccine supplies in 2022, said Dr Abdou Salam Gueye, Director of Emergency Preparedness and Response, WHO […] Continue reading -> WHO Slams Ethiopia’s ‘Blockade’ on Health Relief to Tigray Region as ‘Catastrophic’ and ‘Unprecedented’ Even in Conflict Zones 13/01/2022 Paul Adepoju The leadership of the World Health Organization (WHO) has slammed Ethiopia’s “complete blockade” on health and humanitarian aid to Ethiopia’s Tigray region, saying it has been unable to deliver life-saving medications for nearly six months – in a situation that is “unprecedented” even in comparison to conflict-wracked Syria or Yemen. “Humanitarian access even in conflict […] Continue reading -> South Africa’s New COVID-19 Antigen Test is Able to Detect Omicron 12/01/2022 Kerry Cullinan CAPE TOWN – A locally produced COVID-19 rapid antigen test that was recently approved by South Africa’s medicines regulator is able to detect Omicron, according to its developer. This follows some controversy about whether antigen tests were able to detect Omicron, and suggestions that throat swabs might be more effective than nasal swabs as Omicron […] Continue reading -> India’s Call for WTO Meeting on COVID-19 Response is ‘Premature’, Says EU 11/01/2022 Kerry Cullinan The European Union (EU) has described India’s call for an urgent meeting of the World Trade Organization (WTO) Ministerial Conference to discuss the body’s response to the COVID-19 pandemic, including a proposed waiver of relevant intellectual property protections, as “premature”. Addressing the WTO General Council informal meeting on Monday, EU Ambassador João Aguiar Machado said […] Continue reading -> Bangladesh Produces First Generic of Pfizer’s Antiviral But Indian Company Hits Snag with its Merck Generic 11/01/2022 Kerry Cullinan The first generic version of Paxlovid, the Pfizer pill that has proven highly effective in treating COVID-19, is already available in Bangladesh. However, Indian generic company Dr Reddy’s, which has started to produce the Merck antiviral, molnupiravir, might be in trouble after the country’s National Task Force for COVID-19 resolved on Monday that there were […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
France Approves COVID-19 Vaccine Pass Law, Joins Other EU Countries With COVID Fines and Mandates 17/01/2022 Raisa Santos France’s newest measure to tackle COVID-19 – requiring a certificate of vaccination at public places such as restaurants, cafes, cinemas, and long-distance trains – was approved by its parliament on Sunday. With lawmakers in the lower house of parliament voting 215 to 58 in favour, the law is set to be enforced in coming days. […] Continue reading -> COVAX Delivers One Billionth COVID-19 Vaccine Dose – But 41% of World Remains Unvaccinated 17/01/2022 Kerry Cullinan Rwanda became the recipient of the one-billionth COVID-19 vaccine delivered by COVAX, the global platform set up to ensure equitable access to the vaccines,announced last Friday. After numerous supply problems – most seriously when its key supplier, the Serum Insitute of India, was banned from exporting its vaccines by the Indian government – COVAX was […] Continue reading -> Throat Swab? Nose? Best Test Yet of Omicron’s Spread May be a Sewage Sample 14/01/2022 Maayan Hoffman Two years into the COVID-19 pandemic, monitoring sewage for evidence of disease – in this case COVID-19 – may be on the verge of becoming mainstream. At least that is what some trend-setting researchers are hoping to detect rising SARS-CoV2 infections early and set policies based on data even before swab testing can provide it. […] Continue reading -> WHO Recommends Two New COVID-19 Treatments – Cost and Availability Likely Barriers 14/01/2022 Maayan Hoffman Two new treatments for COVID-19 were recommended on Thursday by the World Health Organization’s Guideline Development Group of international experts – one for severely ill patients and the other for those patients who are not severely ill but most likely to develop severe disease. The recommendations were announced Friday morning in the BMJ. Both drugs, […] Continue reading -> WHO Africa Region: COVID-19 Vaccination Shifting from Supply-Side to Distribution Challenge 13/01/2022 Paul Adepoju COVID-19 vaccination in Africa may be shifting from a supply challenge – to one of effective vaccine distribution, declared a senior World Health Organization official in the African Region on Thursday. African countries will have adequate access to COVID-19 vaccine supplies in 2022, said Dr Abdou Salam Gueye, Director of Emergency Preparedness and Response, WHO […] Continue reading -> WHO Slams Ethiopia’s ‘Blockade’ on Health Relief to Tigray Region as ‘Catastrophic’ and ‘Unprecedented’ Even in Conflict Zones 13/01/2022 Paul Adepoju The leadership of the World Health Organization (WHO) has slammed Ethiopia’s “complete blockade” on health and humanitarian aid to Ethiopia’s Tigray region, saying it has been unable to deliver life-saving medications for nearly six months – in a situation that is “unprecedented” even in comparison to conflict-wracked Syria or Yemen. “Humanitarian access even in conflict […] Continue reading -> South Africa’s New COVID-19 Antigen Test is Able to Detect Omicron 12/01/2022 Kerry Cullinan CAPE TOWN – A locally produced COVID-19 rapid antigen test that was recently approved by South Africa’s medicines regulator is able to detect Omicron, according to its developer. This follows some controversy about whether antigen tests were able to detect Omicron, and suggestions that throat swabs might be more effective than nasal swabs as Omicron […] Continue reading -> India’s Call for WTO Meeting on COVID-19 Response is ‘Premature’, Says EU 11/01/2022 Kerry Cullinan The European Union (EU) has described India’s call for an urgent meeting of the World Trade Organization (WTO) Ministerial Conference to discuss the body’s response to the COVID-19 pandemic, including a proposed waiver of relevant intellectual property protections, as “premature”. Addressing the WTO General Council informal meeting on Monday, EU Ambassador João Aguiar Machado said […] Continue reading -> Bangladesh Produces First Generic of Pfizer’s Antiviral But Indian Company Hits Snag with its Merck Generic 11/01/2022 Kerry Cullinan The first generic version of Paxlovid, the Pfizer pill that has proven highly effective in treating COVID-19, is already available in Bangladesh. However, Indian generic company Dr Reddy’s, which has started to produce the Merck antiviral, molnupiravir, might be in trouble after the country’s National Task Force for COVID-19 resolved on Monday that there were […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
COVAX Delivers One Billionth COVID-19 Vaccine Dose – But 41% of World Remains Unvaccinated 17/01/2022 Kerry Cullinan Rwanda became the recipient of the one-billionth COVID-19 vaccine delivered by COVAX, the global platform set up to ensure equitable access to the vaccines,announced last Friday. After numerous supply problems – most seriously when its key supplier, the Serum Insitute of India, was banned from exporting its vaccines by the Indian government – COVAX was […] Continue reading -> Throat Swab? Nose? Best Test Yet of Omicron’s Spread May be a Sewage Sample 14/01/2022 Maayan Hoffman Two years into the COVID-19 pandemic, monitoring sewage for evidence of disease – in this case COVID-19 – may be on the verge of becoming mainstream. At least that is what some trend-setting researchers are hoping to detect rising SARS-CoV2 infections early and set policies based on data even before swab testing can provide it. […] Continue reading -> WHO Recommends Two New COVID-19 Treatments – Cost and Availability Likely Barriers 14/01/2022 Maayan Hoffman Two new treatments for COVID-19 were recommended on Thursday by the World Health Organization’s Guideline Development Group of international experts – one for severely ill patients and the other for those patients who are not severely ill but most likely to develop severe disease. The recommendations were announced Friday morning in the BMJ. Both drugs, […] Continue reading -> WHO Africa Region: COVID-19 Vaccination Shifting from Supply-Side to Distribution Challenge 13/01/2022 Paul Adepoju COVID-19 vaccination in Africa may be shifting from a supply challenge – to one of effective vaccine distribution, declared a senior World Health Organization official in the African Region on Thursday. African countries will have adequate access to COVID-19 vaccine supplies in 2022, said Dr Abdou Salam Gueye, Director of Emergency Preparedness and Response, WHO […] Continue reading -> WHO Slams Ethiopia’s ‘Blockade’ on Health Relief to Tigray Region as ‘Catastrophic’ and ‘Unprecedented’ Even in Conflict Zones 13/01/2022 Paul Adepoju The leadership of the World Health Organization (WHO) has slammed Ethiopia’s “complete blockade” on health and humanitarian aid to Ethiopia’s Tigray region, saying it has been unable to deliver life-saving medications for nearly six months – in a situation that is “unprecedented” even in comparison to conflict-wracked Syria or Yemen. “Humanitarian access even in conflict […] Continue reading -> South Africa’s New COVID-19 Antigen Test is Able to Detect Omicron 12/01/2022 Kerry Cullinan CAPE TOWN – A locally produced COVID-19 rapid antigen test that was recently approved by South Africa’s medicines regulator is able to detect Omicron, according to its developer. This follows some controversy about whether antigen tests were able to detect Omicron, and suggestions that throat swabs might be more effective than nasal swabs as Omicron […] Continue reading -> India’s Call for WTO Meeting on COVID-19 Response is ‘Premature’, Says EU 11/01/2022 Kerry Cullinan The European Union (EU) has described India’s call for an urgent meeting of the World Trade Organization (WTO) Ministerial Conference to discuss the body’s response to the COVID-19 pandemic, including a proposed waiver of relevant intellectual property protections, as “premature”. Addressing the WTO General Council informal meeting on Monday, EU Ambassador João Aguiar Machado said […] Continue reading -> Bangladesh Produces First Generic of Pfizer’s Antiviral But Indian Company Hits Snag with its Merck Generic 11/01/2022 Kerry Cullinan The first generic version of Paxlovid, the Pfizer pill that has proven highly effective in treating COVID-19, is already available in Bangladesh. However, Indian generic company Dr Reddy’s, which has started to produce the Merck antiviral, molnupiravir, might be in trouble after the country’s National Task Force for COVID-19 resolved on Monday that there were […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Throat Swab? Nose? Best Test Yet of Omicron’s Spread May be a Sewage Sample 14/01/2022 Maayan Hoffman Two years into the COVID-19 pandemic, monitoring sewage for evidence of disease – in this case COVID-19 – may be on the verge of becoming mainstream. At least that is what some trend-setting researchers are hoping to detect rising SARS-CoV2 infections early and set policies based on data even before swab testing can provide it. […] Continue reading -> WHO Recommends Two New COVID-19 Treatments – Cost and Availability Likely Barriers 14/01/2022 Maayan Hoffman Two new treatments for COVID-19 were recommended on Thursday by the World Health Organization’s Guideline Development Group of international experts – one for severely ill patients and the other for those patients who are not severely ill but most likely to develop severe disease. The recommendations were announced Friday morning in the BMJ. Both drugs, […] Continue reading -> WHO Africa Region: COVID-19 Vaccination Shifting from Supply-Side to Distribution Challenge 13/01/2022 Paul Adepoju COVID-19 vaccination in Africa may be shifting from a supply challenge – to one of effective vaccine distribution, declared a senior World Health Organization official in the African Region on Thursday. African countries will have adequate access to COVID-19 vaccine supplies in 2022, said Dr Abdou Salam Gueye, Director of Emergency Preparedness and Response, WHO […] Continue reading -> WHO Slams Ethiopia’s ‘Blockade’ on Health Relief to Tigray Region as ‘Catastrophic’ and ‘Unprecedented’ Even in Conflict Zones 13/01/2022 Paul Adepoju The leadership of the World Health Organization (WHO) has slammed Ethiopia’s “complete blockade” on health and humanitarian aid to Ethiopia’s Tigray region, saying it has been unable to deliver life-saving medications for nearly six months – in a situation that is “unprecedented” even in comparison to conflict-wracked Syria or Yemen. “Humanitarian access even in conflict […] Continue reading -> South Africa’s New COVID-19 Antigen Test is Able to Detect Omicron 12/01/2022 Kerry Cullinan CAPE TOWN – A locally produced COVID-19 rapid antigen test that was recently approved by South Africa’s medicines regulator is able to detect Omicron, according to its developer. This follows some controversy about whether antigen tests were able to detect Omicron, and suggestions that throat swabs might be more effective than nasal swabs as Omicron […] Continue reading -> India’s Call for WTO Meeting on COVID-19 Response is ‘Premature’, Says EU 11/01/2022 Kerry Cullinan The European Union (EU) has described India’s call for an urgent meeting of the World Trade Organization (WTO) Ministerial Conference to discuss the body’s response to the COVID-19 pandemic, including a proposed waiver of relevant intellectual property protections, as “premature”. Addressing the WTO General Council informal meeting on Monday, EU Ambassador João Aguiar Machado said […] Continue reading -> Bangladesh Produces First Generic of Pfizer’s Antiviral But Indian Company Hits Snag with its Merck Generic 11/01/2022 Kerry Cullinan The first generic version of Paxlovid, the Pfizer pill that has proven highly effective in treating COVID-19, is already available in Bangladesh. However, Indian generic company Dr Reddy’s, which has started to produce the Merck antiviral, molnupiravir, might be in trouble after the country’s National Task Force for COVID-19 resolved on Monday that there were […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Recommends Two New COVID-19 Treatments – Cost and Availability Likely Barriers 14/01/2022 Maayan Hoffman Two new treatments for COVID-19 were recommended on Thursday by the World Health Organization’s Guideline Development Group of international experts – one for severely ill patients and the other for those patients who are not severely ill but most likely to develop severe disease. The recommendations were announced Friday morning in the BMJ. Both drugs, […] Continue reading -> WHO Africa Region: COVID-19 Vaccination Shifting from Supply-Side to Distribution Challenge 13/01/2022 Paul Adepoju COVID-19 vaccination in Africa may be shifting from a supply challenge – to one of effective vaccine distribution, declared a senior World Health Organization official in the African Region on Thursday. African countries will have adequate access to COVID-19 vaccine supplies in 2022, said Dr Abdou Salam Gueye, Director of Emergency Preparedness and Response, WHO […] Continue reading -> WHO Slams Ethiopia’s ‘Blockade’ on Health Relief to Tigray Region as ‘Catastrophic’ and ‘Unprecedented’ Even in Conflict Zones 13/01/2022 Paul Adepoju The leadership of the World Health Organization (WHO) has slammed Ethiopia’s “complete blockade” on health and humanitarian aid to Ethiopia’s Tigray region, saying it has been unable to deliver life-saving medications for nearly six months – in a situation that is “unprecedented” even in comparison to conflict-wracked Syria or Yemen. “Humanitarian access even in conflict […] Continue reading -> South Africa’s New COVID-19 Antigen Test is Able to Detect Omicron 12/01/2022 Kerry Cullinan CAPE TOWN – A locally produced COVID-19 rapid antigen test that was recently approved by South Africa’s medicines regulator is able to detect Omicron, according to its developer. This follows some controversy about whether antigen tests were able to detect Omicron, and suggestions that throat swabs might be more effective than nasal swabs as Omicron […] Continue reading -> India’s Call for WTO Meeting on COVID-19 Response is ‘Premature’, Says EU 11/01/2022 Kerry Cullinan The European Union (EU) has described India’s call for an urgent meeting of the World Trade Organization (WTO) Ministerial Conference to discuss the body’s response to the COVID-19 pandemic, including a proposed waiver of relevant intellectual property protections, as “premature”. Addressing the WTO General Council informal meeting on Monday, EU Ambassador João Aguiar Machado said […] Continue reading -> Bangladesh Produces First Generic of Pfizer’s Antiviral But Indian Company Hits Snag with its Merck Generic 11/01/2022 Kerry Cullinan The first generic version of Paxlovid, the Pfizer pill that has proven highly effective in treating COVID-19, is already available in Bangladesh. However, Indian generic company Dr Reddy’s, which has started to produce the Merck antiviral, molnupiravir, might be in trouble after the country’s National Task Force for COVID-19 resolved on Monday that there were […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Africa Region: COVID-19 Vaccination Shifting from Supply-Side to Distribution Challenge 13/01/2022 Paul Adepoju COVID-19 vaccination in Africa may be shifting from a supply challenge – to one of effective vaccine distribution, declared a senior World Health Organization official in the African Region on Thursday. African countries will have adequate access to COVID-19 vaccine supplies in 2022, said Dr Abdou Salam Gueye, Director of Emergency Preparedness and Response, WHO […] Continue reading -> WHO Slams Ethiopia’s ‘Blockade’ on Health Relief to Tigray Region as ‘Catastrophic’ and ‘Unprecedented’ Even in Conflict Zones 13/01/2022 Paul Adepoju The leadership of the World Health Organization (WHO) has slammed Ethiopia’s “complete blockade” on health and humanitarian aid to Ethiopia’s Tigray region, saying it has been unable to deliver life-saving medications for nearly six months – in a situation that is “unprecedented” even in comparison to conflict-wracked Syria or Yemen. “Humanitarian access even in conflict […] Continue reading -> South Africa’s New COVID-19 Antigen Test is Able to Detect Omicron 12/01/2022 Kerry Cullinan CAPE TOWN – A locally produced COVID-19 rapid antigen test that was recently approved by South Africa’s medicines regulator is able to detect Omicron, according to its developer. This follows some controversy about whether antigen tests were able to detect Omicron, and suggestions that throat swabs might be more effective than nasal swabs as Omicron […] Continue reading -> India’s Call for WTO Meeting on COVID-19 Response is ‘Premature’, Says EU 11/01/2022 Kerry Cullinan The European Union (EU) has described India’s call for an urgent meeting of the World Trade Organization (WTO) Ministerial Conference to discuss the body’s response to the COVID-19 pandemic, including a proposed waiver of relevant intellectual property protections, as “premature”. Addressing the WTO General Council informal meeting on Monday, EU Ambassador João Aguiar Machado said […] Continue reading -> Bangladesh Produces First Generic of Pfizer’s Antiviral But Indian Company Hits Snag with its Merck Generic 11/01/2022 Kerry Cullinan The first generic version of Paxlovid, the Pfizer pill that has proven highly effective in treating COVID-19, is already available in Bangladesh. However, Indian generic company Dr Reddy’s, which has started to produce the Merck antiviral, molnupiravir, might be in trouble after the country’s National Task Force for COVID-19 resolved on Monday that there were […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Slams Ethiopia’s ‘Blockade’ on Health Relief to Tigray Region as ‘Catastrophic’ and ‘Unprecedented’ Even in Conflict Zones 13/01/2022 Paul Adepoju The leadership of the World Health Organization (WHO) has slammed Ethiopia’s “complete blockade” on health and humanitarian aid to Ethiopia’s Tigray region, saying it has been unable to deliver life-saving medications for nearly six months – in a situation that is “unprecedented” even in comparison to conflict-wracked Syria or Yemen. “Humanitarian access even in conflict […] Continue reading -> South Africa’s New COVID-19 Antigen Test is Able to Detect Omicron 12/01/2022 Kerry Cullinan CAPE TOWN – A locally produced COVID-19 rapid antigen test that was recently approved by South Africa’s medicines regulator is able to detect Omicron, according to its developer. This follows some controversy about whether antigen tests were able to detect Omicron, and suggestions that throat swabs might be more effective than nasal swabs as Omicron […] Continue reading -> India’s Call for WTO Meeting on COVID-19 Response is ‘Premature’, Says EU 11/01/2022 Kerry Cullinan The European Union (EU) has described India’s call for an urgent meeting of the World Trade Organization (WTO) Ministerial Conference to discuss the body’s response to the COVID-19 pandemic, including a proposed waiver of relevant intellectual property protections, as “premature”. Addressing the WTO General Council informal meeting on Monday, EU Ambassador João Aguiar Machado said […] Continue reading -> Bangladesh Produces First Generic of Pfizer’s Antiviral But Indian Company Hits Snag with its Merck Generic 11/01/2022 Kerry Cullinan The first generic version of Paxlovid, the Pfizer pill that has proven highly effective in treating COVID-19, is already available in Bangladesh. However, Indian generic company Dr Reddy’s, which has started to produce the Merck antiviral, molnupiravir, might be in trouble after the country’s National Task Force for COVID-19 resolved on Monday that there were […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
South Africa’s New COVID-19 Antigen Test is Able to Detect Omicron 12/01/2022 Kerry Cullinan CAPE TOWN – A locally produced COVID-19 rapid antigen test that was recently approved by South Africa’s medicines regulator is able to detect Omicron, according to its developer. This follows some controversy about whether antigen tests were able to detect Omicron, and suggestions that throat swabs might be more effective than nasal swabs as Omicron […] Continue reading -> India’s Call for WTO Meeting on COVID-19 Response is ‘Premature’, Says EU 11/01/2022 Kerry Cullinan The European Union (EU) has described India’s call for an urgent meeting of the World Trade Organization (WTO) Ministerial Conference to discuss the body’s response to the COVID-19 pandemic, including a proposed waiver of relevant intellectual property protections, as “premature”. Addressing the WTO General Council informal meeting on Monday, EU Ambassador João Aguiar Machado said […] Continue reading -> Bangladesh Produces First Generic of Pfizer’s Antiviral But Indian Company Hits Snag with its Merck Generic 11/01/2022 Kerry Cullinan The first generic version of Paxlovid, the Pfizer pill that has proven highly effective in treating COVID-19, is already available in Bangladesh. However, Indian generic company Dr Reddy’s, which has started to produce the Merck antiviral, molnupiravir, might be in trouble after the country’s National Task Force for COVID-19 resolved on Monday that there were […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
India’s Call for WTO Meeting on COVID-19 Response is ‘Premature’, Says EU 11/01/2022 Kerry Cullinan The European Union (EU) has described India’s call for an urgent meeting of the World Trade Organization (WTO) Ministerial Conference to discuss the body’s response to the COVID-19 pandemic, including a proposed waiver of relevant intellectual property protections, as “premature”. Addressing the WTO General Council informal meeting on Monday, EU Ambassador João Aguiar Machado said […] Continue reading -> Bangladesh Produces First Generic of Pfizer’s Antiviral But Indian Company Hits Snag with its Merck Generic 11/01/2022 Kerry Cullinan The first generic version of Paxlovid, the Pfizer pill that has proven highly effective in treating COVID-19, is already available in Bangladesh. However, Indian generic company Dr Reddy’s, which has started to produce the Merck antiviral, molnupiravir, might be in trouble after the country’s National Task Force for COVID-19 resolved on Monday that there were […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Bangladesh Produces First Generic of Pfizer’s Antiviral But Indian Company Hits Snag with its Merck Generic 11/01/2022 Kerry Cullinan The first generic version of Paxlovid, the Pfizer pill that has proven highly effective in treating COVID-19, is already available in Bangladesh. However, Indian generic company Dr Reddy’s, which has started to produce the Merck antiviral, molnupiravir, might be in trouble after the country’s National Task Force for COVID-19 resolved on Monday that there were […] Continue reading -> Posts navigation Older postsNewer posts